HC Wainwright & Co. Maintains Buy on Alpine Immune Sciences, Maintains $50 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Alpine Immune Sciences (NASDAQ:ALPN) with a maintained price target of $50.
March 21, 2024 | 3:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpine Immune Sciences maintains a Buy rating and a $50 price target from HC Wainwright & Co.
The maintenance of a Buy rating and a $50 price target by a reputable analyst firm like HC Wainwright & Co. suggests a positive outlook on Alpine Immune Sciences' stock. This endorsement could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100